Meta-analysis results for all treatments

Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method

Treament Trials      
clinical deteriorationclinical improvementdeathsviral clearance
camostat mesilate1- 1.14 [0.83; 1.57], 1 RCT, I2=0%
inconclusive result
0.70 [0.20; 2.49], 1 RCT, I2=0%
inconclusive result
-
2-deoxy-D-glucose (2-DG)0----
acetylcysteine0----
alpha lipoic acid0----
anti-CK20----
Aspirin0----
aviptadil0----
BLD-2660 (calpain inhibitor)0----
calcium channel blocker0----
Cannabidiol0----
continuous positive airway pressure (CPAP)0----
cytokine adsorption0----
diammonium glycyrrhizinate0----
dipyridamol0----
dornase alfa0----
expectorants and mucolytics0----
honey0----
kinin-kallikrein inhibitors0----
melatonin0----
mouthrise and gargling agents0----
N-Acetylcysteine0----
nasal spray0----
natural killer (NK) cells0----
nicotin0----
nigella sativa oil0----
nitric oxide (gas Inhalation or releasing solution)0----
omega-3 Polyunsaturated Fatty Acids0----
ozonated autohemotherapy0----
plasma exchange0----
povidone-iodine0----
previfenon (EGCG)0----
prostacyclin0----
PUL-042 inhalation solution0----
pyridostigmine0----
radiotherapy0----
sabizabulin0----
sildenafil0----
triiodothyronine (T3)0----